SCHEMBL21473610

SCHEMBL21473610

Cc1cccc(N2Cc3ccccc3C2=O)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.69
RAB9A P51151 6/20 0.69
PKM P14618 3/20 0.69
KMT2A Q03164 4/20 0.61
GAA P10253 3/20 0.61
MEN1 O00255 3/20 0.61
CASP6 P55212 1/20 0.61
PARP1 P09874 1/20 0.58
CYP11B2 P19099 1/20 0.56
SMN1; SMN2 Q16637 5/20 0.53
TP53 P04637 3/20 0.53
TSHR P16473 1/20 0.53
UGCG Q16739 1/20 0.52
LMNA P02545 2/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
PGR P06401 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28630259 0.87 NPC1 (0.73) NPC1RAB9APKMKMT2AGAA
SCHEMBL29611011 0.82 NPC1 (1.00) NPC1RAB9APKMKMT2AGAA
SCHEMBL5579208 0.82 NPC1 (1.00) NPC1RAB9APKMKMT2AGAA
SCHEMBL30666441 0.82 NPC1 (0.74) NPC1RAB9APKMKMT2AGAA
SCHEMBL29128053 0.82 NPC1 (0.74) NPC1RAB9APKMKMT2AGAA
SCHEMBL29874794 0.81 NPC1 (1.00) NPC1RAB9APKMKMT2AGAA
SCHEMBL4188221 0.81 NPC1 (1.00) NPC1RAB9APKMKMT2AGAA
SCHEMBL30910320 0.81 NPC1 (0.68) NPC1RAB9APKMKMT2AGAA
SCHEMBL28883282 0.81 NPC1 (0.68) NPC1RAB9APKMKMT2AGAA
SCHEMBL10085509 0.81 NPC1 (0.69) NPC1RAB9APKMKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778586-A1 QUINAZOLINE COMPOUND SERVING AS EGFR TRIPLE MUTATION INHIBITOR AND APPLICATIONS THEREOF East China University of Science and Technology (CN) 2021-02-17 EP disclosed
WO-2019196938-A1 QUINAZOLINE COMPOUND SERVING AS EGFR TRIPLE MUTATION INHIBITOR AND APPLICATIONS THEREOF 华东理工大学 2019-10-17 WO disclosed